IL10 and metabolic disease: Four plant derivatives, perillaldehyde, wogonoside, cinnamaldehyde, and 6-shogaol reduced levels of TNFα without decreasing IL-10, marking these compounds as potential immunomodulatory therapeutics for metabolic disease (Fig. 1b).